Sunil Parikh M.D., M.P.H.
Assistant Professor of Epidemiology (Microbial Diseases) and of Medicine (Infectious Diseases)
Departments & Organizations
translation research in malaria, pharmacology of antimalarials, hiv-malaria co-infection, host response to malaria infection, innate immunity to malaria more...
- M.D., Johns Hopkins University School of Medicine, 1998
- M.P.H., University of California at Berkeley, 2005
- Creek DJ, Bigira V, McCormack S, Arinaitwe E, Wanzira H, Kakuru A, Tappero JW, Sandison TG, Lindegardh N, Nosten F, Aweeka FT, Parikh S. Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants. The Journal of Infectious Diseases. In press.
- Lee TM, Huang L, Johnson MK, Lizak P, Kroetz D, Aweeka F, Parikh S. In vitro metabolism of piperaquine is primarily mediated by CYP3A4. Xenobiotica. 2012: 42(11): 1088-95. PMID: 22671777.
- Tarning J, Zongo I, Some F, Romba N , Parikh S, et al. Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria. Clinical Pharmacology and Therapeutics 2012; 91(3):497-505.